Segment disclosures

Company overview

Camp4 Therapeutics Corp

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

RD

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=camp:RDMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-301779000 USD20260813Open filing evidence
2026-01-01 – 2026-06-303073000 USD20260813Open filing evidence
2026-01-01 – 2026-03-311294000 USD20260507Open filing evidence
2025-01-01 – 2025-12-313498000 USD20260305Open filing evidence
2025-07-01 – 2025-09-30795000 USD20251106Open filing evidence
2025-01-01 – 2025-09-303150000 USD20251106Open filing evidence
2025-04-01 – 2025-06-301497000 USD20260813Open filing evidence
2025-01-01 – 2025-06-302355000 USD20260813Open filing evidence
2025-01-01 – 2025-03-31858000 USD20260507Open filing evidence
2024-01-01 – 2024-12-31652000 USD20260305Open filing evidence
2024-07-01 – 2024-09-300 USD20251106Open filing evidence
2024-01-01 – 2024-09-300 USD20251106Open filing evidence
2024-04-01 – 2024-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-06-300 USD20250814Open filing evidence
2024-01-01 – 2024-03-310 USD20250513Open filing evidence
2023-01-01 – 2023-12-31350000 USD20250327Open filing evidence